Zynerba Pharmaceuticals Inc

NASDAQ:ZYNE 4:00:00 PM EDT

1.28

+0.01 (+0.79%)

: $1.30 +0.02 (+1.56%)

Zynerba Pharmaceuticals Inc Stock, NASDAQ:ZYNE

80 West Lancaster Avenue, Suite 300, Devon, Pennsylvania 19333

United States of America

Phone: +1.484.581.7505

Number of Employees: 27

http://www.zynerba.com

Description

Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on the research and development of rare and near-rare neuropsychiatric conditions. The firm offers the Zygel product, which is formulated as a permeation-enhanced gel for transdermal delivery. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.